Literature DB >> 31679727

Cystic fibrosis related diabetes: Nutrition and growth considerations.

Beth A Kaminski1, Bracha K Goldsweig2, Aniket Sidhaye3, Scott M Blackman4, Teresa Schindler5, Antoinette Moran6.   

Abstract

Nutritional considerations are crucial to the optimal management of cystic fibrosis related diabetes (CFRD). The development of abnormal glucose tolerance and CFRD can have negative effects on CF nutritional status. Treatment of CFRD with insulin replacement is essential; however, medical nutrition therapy is important to maintain nutritional status while normalizing blood glucose levels. CF Foundation Nutritional Guidelines are recommended for the nutritional management of CFRD; specifically, the diet should be high in calories, protein, fat, and salt. Carbohydrate intake is not limited, but carbohydrate counting can be used to guide insulin dosing and maintain consistent blood glucose levels. CFTR modulator therapy shows early promise for the improvement of growth and nutritional parameters in CF.
Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Cystic fibrosis related diabetes; Growth; Nutrition

Year:  2019        PMID: 31679727     DOI: 10.1016/j.jcf.2019.08.011

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  7 in total

1.  Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance.

Authors:  Andrea Kelly; Saba Sheikh; Darko Stefanovski; Amy J Peleckis; Sarah C Nyirjesy; Jack N Eiel; Aniket Sidhaye; Russell Localio; Robert Gallop; Diva D De Leon; Denis Hadjiliadis; Ronald C Rubenstein; Michael R Rickels
Journal:  J Clin Endocrinol Metab       Date:  2021-05-22       Impact factor: 5.958

Review 2.  Overview of Atypical Diabetes.

Authors:  Jaclyn Tamaroff; Marissa Kilberg; Sara E Pinney; Shana McCormack
Journal:  Endocrinol Metab Clin North Am       Date:  2020-10-14       Impact factor: 4.741

Review 3.  Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.

Authors:  Saangyoung E Lee; Zainab Farzal; M Leigh Anne Daniels; Brian D Thorp; Adam M Zanation; Brent A Senior; Charles S Ebert; Adam J Kimple
Journal:  Am J Rhinol Allergy       Date:  2020-03-13       Impact factor: 2.467

4.  Gestational and pregestational diabetes in pregnant women with cystic fibrosis.

Authors:  Rachael Oxman; Andrea H Roe; Ullal Jagdeesh; Melissa S Putman
Journal:  J Clin Transl Endocrinol       Date:  2021-12-05

5.  Cystic Fibrosis-Related Diabetes in Poland.

Authors:  Marta Rachel; Marek Biesiadecki; Sabina Galiniak
Journal:  Int J Environ Res Public Health       Date:  2022-03-29       Impact factor: 3.390

Review 6.  Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management.

Authors:  Dhiren Patel; Albert Shan; Stacy Mathews; Meghana Sathe
Journal:  Nutrients       Date:  2022-02-28       Impact factor: 5.717

7.  Prepuberal insulin secretory indices are long-term predictors of short adult stature in cystic fibrosis.

Authors:  Alberto Battezzati; Andrea Foppiani; Gianfranco Alicandro; Arianna Bisogno; Arianna Biffi; Giorgio Bedogni; Simona Bertoli; Giulia De Carlo; Erica Nazzari; Carla Colombo
Journal:  Endocr Connect       Date:  2022-05-10       Impact factor: 3.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.